April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Retinas from STZ-induced diabetic rats present angiographic and focal ERG alterations as well as anti-angiogenic factors inhibition.
Author Affiliations & Notes
  • Anna Salas Torras
    Ophthalmology, Vall Hebron Hospital, Research Institute, Barcelona, Spain
  • Marina Riera
    Ophthalmology, Vall Hebron Hospital, Research Institute, Barcelona, Spain
  • Miguel A Zapata
    Ophthalmology, Vall Hebron Hospital, Research Institute, Barcelona, Spain
  • Ibane Abasolo
    CIBBIM-Nanomedicine, Vall Hebron Hospital, Research Institute, Barcelona, Spain
  • Simo Schwartz
    CIBBIM-Nanomedicine, Vall Hebron Hospital, Research Institute, Barcelona, Spain
  • Jose Garcia-Arumi
    Ophthalmology, Vall Hebron Hospital, Research Institute, Barcelona, Spain
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 2249. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Anna Salas Torras, Marina Riera, Miguel A Zapata, Ibane Abasolo, Simo Schwartz, Jose Garcia-Arumi; Retinas from STZ-induced diabetic rats present angiographic and focal ERG alterations as well as anti-angiogenic factors inhibition.. Invest. Ophthalmol. Vis. Sci. 2014;55(13):2249.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: The aim of this study is to characterize the ocular alterations of the STZ-induced diabetes model through fluorescence angiography (FA), focal electroretinogram (fERG), and angiogenesis-related factors study by immunohistochemistry and gene expression.

Methods: 6-week-old Long Evans male rats were randomly assigned to treated (65 mg/kg STZ) and control groups (1 ml/kg citrate buffer) and divided into four time-points (1, 2, 4 and 8 weeks of diabetes). Two days after STZ administration, glucose levels were measured to assess the hyperglycemia in the STZ-treated animals. Inner and outer retinal functions were measured by fERG every week, comparing central and peripheral retina. Once a week, animals were injected with fluorescein and FA were taken to study vascular abnormalities. After each time-point animals were euthanized and eyes were enucleated. Left eyes were fixed with 4% paraformaldehide and frozen on TFM for cryosection and retinas from right eyes were isolated and frozen for RNA extraction and real time PCR. Gene and protein expression of the main angiogenesis-related factors (VEGF as the principal angiogenesis promoter and PEDF and SST as two of the most important anti-angiogenic factors) was determined.

Results: fERG measurements showed a significant reduction of the oscillatory potentials after 8 weeks of diabetes, being higher in central retina, demonstrating inner-retinal dysfunction. Fluorescence angiographies showed increased vessel tortuosity and vascular leakage starting at week 2 after treatment, evidencing diabetes-driven retinal vascular abnormalities. Post-mortem analysis showed increased VEGF levels, glial activation and apoptosis in retinas of STZ rats compared with controls, as well as lower PEDF and SST levels.

Conclusions: Taken together, these data give new evidences on the ocular alterations in the STZ-induced diabetes model, suggesting that this is a good aproach for the study of proliferative diabetic retinopathy, highlighting the neural and vascular abnormalities as well as proposing it for the study of neuroprotective and anti-angiogenic agents.

Keywords: 499 diabetic retinopathy • 609 neovascularization  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×